GR-011

N/A

Report date: 2024/11/08 10:39:15

Base Information

Drug NameGR-011
Drug Alias NameGR-011GR011
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionT-cell surface antigen CD4 agonists
TargetsT-cell surface antigen CD4
Therapy Area/IndicationsLung NeoplasmsLiver NeoplasmsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesJiaochen Biological Medicine Technology (Shanghai) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJiaochen Biological Medicine Technology (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsLung NeoplasmsLiver NeoplasmsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A